Clarivate Plc
NYSE:CLVT
Sector
Location
Market Cap
USD 2.70 B
Share Price
USD 4.02
Avg Daily Volume
5,191,924
Change (1 day)
2.29%
Change (1 year)
-27.04%
Change (YTD)
-20.87%
Clarivate Plc Common Stock Issued for the Trailing 12 Months (TTM) ending December 31, 2024: USD 0.00
Clarivate Plc Common Stock Issued is USD 0.00 for the Trailing 12 Months (TTM) ending December 31, 2024. Common stock issued is cash received from issuing new shares of the company’s common stock.
-
Clarivate Plc Common Stock Issued for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 0.00, a -100.00% change year over year.
-
Clarivate Plc Common Stock Issued for the Trailing 12 Months (TTM) ending December 31, 2022 was USD 5.80 M, a -99.34% change year over year.
-
Clarivate Plc Common Stock Issued for the Trailing 12 Months (TTM) ending December 31, 2021 was USD 872.97 M, a 3.45% change year over year.
-
Clarivate Plc Common Stock Issued for the Trailing 12 Months (TTM) ending December 31, 2020 was USD 843.87 M.
StockViz
Competitors
Eli Lilly and Company
USD 639.43
LLY
+4.21
0.66%
AbbVie Inc.
USD 198.64
ABBV
-0.06
-0.03%
Roche Holding AG
USD 320.12
RO.SW
+2.62
0.83%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 131.02
ABT
-0.34
-0.26%
Novartis AG
USD 119.03
NOVN.SW
+1.05
0.89%
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
-0.09
-0.18%
Merck & Co., Inc.
USD 80.30
MRK
+0.27
0.34%
Thermo Fisher Scientific Inc.
USD 477.41
TMO
+15.02
3.25%
Amgen Inc.
USD 284.98
AMGN
-0.11
-0.04%
Gilead Sciences, Inc.
USD 120.02
GILD
-0.45
-0.37%
Pfizer Inc.
USD 24.65
PFE
+0.07
0.29%
Sanofi
USD 95.31
SAN.PA
+0.83
0.88%
Vertex Pharmaceuticals Incorporated
USD 387.77
VRTX
+13.31
3.55%
Bristol-Myers Squibb Company
USD 46.55
BMY
+0.62
1.35%
Key Data
| Date | Common Stock Issued | Common Stock Repurchased | Free Cash Flow | Operating Cash Flow |
|---|
Competitors
Eli Lilly and Company
USD 639.43
LLY
+4.21
0.66%
AbbVie Inc.
USD 198.64
ABBV
-0.06
-0.03%
Roche Holding AG
USD 320.12
RO.SW
+2.62
0.83%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 131.02
ABT
-0.34
-0.26%
Novartis AG
USD 119.03
NOVN.SW
+1.05
0.89%
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
-0.09
-0.18%
Merck & Co., Inc.
USD 80.30
MRK
+0.27
0.34%
Thermo Fisher Scientific Inc.
USD 477.41
TMO
+15.02
3.25%
Amgen Inc.
USD 284.98
AMGN
-0.11
-0.04%
Gilead Sciences, Inc.
USD 120.02
GILD
-0.45
-0.37%
Pfizer Inc.
USD 24.65
PFE
+0.07
0.29%
Sanofi
USD 95.31
SAN.PA
+0.83
0.88%
Vertex Pharmaceuticals Incorporated
USD 387.77
VRTX
+13.31
3.55%
Bristol-Myers Squibb Company
USD 46.55
BMY
+0.62
1.35%